Search results for "Highlights"


 
Results 21 - 30 of about 85 for "Highlights".

Highlights

A randomized trial of three polyethylene glycol regimens found that more patients tolerated and were willing to repeat low-volume same-day or split-dose prep compared to high-volume split-dose regimens.
August 2020

Guideline released on treatment of Helicobacter pylori infection

Clarithromycin triple therapy should be used for first-line treatment of Helicobacter pylori infection only in patients with no history of macrolide exposure who live in areas where H. pylori resistance to clarithromycin is known to be low, among
January 2017

GI safety profile varies among direct oral anticoagulants

Three propensity-matched cohorts of patients with nonvalvular atrial fibrillation who had incident exposure to dabigatran, rivaroxaban, or apixaban were compared.
January 2017

Spotlight on nonalcoholic fatty liver disease and cardiac risk

Additionally, our results highlight the potential clinical utility of echocardiography for assessing NAFLD-related HF risk.
August 2017

Induction, maintenance therapies for ulcerative colitis compared

Oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine, controlled ileal-release budesonide, and budesonide multimatrix, alone or in combination with rectal 5-ASA therapy, were assessed for comparative efficacy and tolerability.
August 2018

Introducing ACP Gastroenterology Monthly

Welcome to the first issue of ACP Gastroenterology Monthly, a new free monthly e-newsletter from the American College of Physicians, designed to inform primary care physicians of the current literature in gastroenterology/hepatology.
January 2017

Highlights

There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
May 2019

Highlights

A randomized trial found that median length of hospital stay was 40.0 hours in the antibiotic group and 45.8 hours in the placebo group, with no significant between-group differences in adverse events or readmissions.
April 2020

Endoscopic eradication therapy plus reflux control associated with decreased Barrett's recurrence rates

Standard reflux management protocol involved initial consultation that emphasized reflux control and proton-pump inhibitor (PPI) adherence, initiation or continuation of PPI therapy as described, medication reconciliation and assessment or
February 2017

Highlights

An editorial said the results highlight the importance of alternative biologic treatments and regimens for some patients but noted that further research is needed on cost-effectiveness.
September 2019

Result Page: Prev   1   2   3   4   5   6   7   8   9   Next